Share buyback program – Ipsen reporting from 01 to 05 August 2022 – Detailed
Share buyback program – Ipsen reporting from 01 to 05 August 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
Attachment
Share buyback program – Ipsen reporting from 01 to 05 August 2022 – Detailed
- 09 August 2022 - 1 mins read
This article or press release has no online content. Please download the associated documents for more information.
Attachment
Related Press Releases
07 March 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
15 February 2024
1 mins read
Ipsen S.A. publishes its 2023 Consolidated Financial Statements
13 February 2024
14 mins read
Ipsen’s Onivyde® regimen, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma, approved by FDA
08 February 2024
8 mins read
Building on solid FY 2023 results, Ipsen anticipates four launches in 2024
06 February 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
22 January 2024
10 mins read
Latest Phase III trial data investigating Cabometyx® in combination with immunotherapy to be presented at ASCO GU 2024
08 January 2024
1 mins read
Ipsen – Half year statement – 2023 12 31
05 January 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
07 December 2023
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
07 December 2023
10 mins read